Cizumab 400 — Bevacizumab 400 mg / 16 ml, 1 pcs, Hetero
100% original product

Cizumab 400 (Bevacizumab) 400 mg/16 mL Cold chain · Storage +2…+8 °C

10112 11236 -10%
Cold chain Storage +2…+8 °C

This medicine requires temperature control. We pack it in a thermal box with cold packs for safe delivery.

Please return the thermal box with cold packs after delivery. An additional charge applies only if you wish to keep the box.

Cizumab 400 (Bevacizumab 400 mg/16 ml) is a potent targeted therapy agent supplied in a larger vial size.

Manufacturer: Hetero Healthcare (India). It is a biosimilar to Avastin. The 400 mg vial is designed for convenient dosing in adult patients with higher body weight or dose requirements.

Mechanism of Action ("Anti-Angiogenesis"):

Bevacizumab works by neutralizing the Vascular Endothelial Growth Factor (VEGF). By blocking VEGF, it prevents the tumor from growing the new blood vessels it needs to survive. Essentially, it cuts off the tumor's supply line of oxygen and nutrients ("starving" the cancer).

Key Benefit: Slows tumor progression and improves survival rates in metastatic cancers.

Indicated for advanced or metastatic cancers:

  • 🎗 Colorectal Cancer: Metastatic carcinoma of the colon or rectum.
  • 🫁 Non-Small Cell Lung Cancer (NSCLC): Non-squamous type.
  • 🧠 Glioblastoma: Recurrent malignant brain tumors.
  • 🥚 Ovarian Cancer: Advanced epithelial ovarian cancer.
  • Renal Cell Carcinoma (Kidney Cancer).

Packaging: 16 ml Vial (Concentration 25 mg/ml = Total 400 mg).

⚠️ ADMINISTRATION GUIDELINES:

  • 💉 IV Infusion: Must be diluted in 0.9% Sodium Chloride only. NEVER mix with Dextrose/Glucose solutions.
  • Dosing: Calculated based on body weight (mg/kg). Infusion time starts at 90 minutes and may be reduced if tolerated.
  • 🔪 Surgery Warning: Discontinue use at least 28 days prior to elective surgery due to wound healing complications.

  • Pregnancy and breastfeeding (teratogenic risk).
  • History of hypertensive crisis.
  • Recent hemoptysis (coughing up blood) or serious hemorrhage.
  • Hypersensitivity to recombinant antibodies.

Potential side effects associated with VEGF inhibition:

  • 🩸 Hemorrhage: Epistaxis (nosebleeds) is common; internal bleeding is a risk.
  • Hypertension: Elevated blood pressure requiring monitoring.
  • 🩹 Wound Healing: Delayed healing of surgical incisions.
  • Fatigue, proteinuria.

Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 17.06.2026

Active ingredient
Storage temperature
Cold chain · Storage +2…+8 °C

Shipped in a thermal box with cold packs

Manufacturer
Hetero
Dosage
400 mg / 16 ml
Dosage form Concentrate for solution for infusion
Vials per pack 1
100% original product
Delivery across Ukraine
Customer reviews

What Customers Say

No reviews yet

Your review can be the first!

Contact us

Choose a convenient way to contact

We work daily from 9:00 to 20:00